TheOphthoManual
Neuro-Ophthalmology

Pupillary Examination & the Swinging Flashlight Test (RAPD)

Last updated 2026-07-29 · Drafted from 2 cited sources

Purpose

The pupillary exam, and specifically the swinging flashlight test, detects a relative afferent pupillary defect (RAPD) — an asymmetry in the afferent (sensory) visual pathway between the two eyes. Because both pupils normally constrict equally regardless of which eye is stimulated (the consensual reflex), the swinging flashlight test isolates afferent pathway dysfunction (optic nerve or severe, extensive retinal disease) from efferent (motor, third-nerve or iris) abnormalities, which affect only the ipsilateral pupil's direct response.

Equipment

  • A bright, handheld penlight or transilluminator
  • A dimly lit room (dim, not dark, since the room needs enough ambient light to observe the resting pupil size without additional light stimulating a response)

Steps

  1. Dim the room lights and have the patient fixate on a distant target to minimize a near-response confound.
  2. Shine the light on one pupil for 3-5 seconds, observing the direct response (constriction of the illuminated pupil).
  3. Swiftly swing the light to the other eye (moving quickly across the bridge of the nose, minimizing the time both pupils are in darkness) and observe that pupil's response.
  4. Continue swinging the light back and forth every 3-5 seconds, comparing each pupil's response to direct illumination.
  5. A normal result: each pupil constricts equally (or very slightly further constricts due to consensual reinforcement) each time the light lands on it.
  6. An abnormal (positive RAPD) result: when the light swings to the affected eye, that pupil appears to paradoxically dilate (or constrict less briskly and to a lesser degree) compared to the other eye, since the afferent signal from that eye is weaker than the consensual signal it had just been receiving from the other eye's stimulation.
  7. Grade the RAPD if present, typically using neutral density filters of increasing strength placed in front of the unaffected eye until the apparent defect is neutralized, providing a semi-quantitative severity estimate.

Normal vs. Abnormal Findings

  • Normal: symmetric constriction of both pupils regardless of which eye is directly illuminated; no side-to-side difference in response briskness or amplitude.
  • Positive RAPD (Marcus Gunn pupil): the affected eye's pupil dilates (or constricts less) when the light swings to it, indicating a weaker afferent signal from that eye relative to the other — classically from unilateral or markedly asymmetric optic neuropathy (optic neuritis, ischemic optic neuropathy, compressive lesion, glaucoma) or extensive unilateral retinal disease (large retinal detachment, central retinal artery/vein occlusion).
  • No RAPD despite unilateral vision loss: suggests the vision loss is not due to afferent pathway dysfunction on that side, but rather from a refractive, media (cataract), or bilaterally symmetric process, or a non-organic cause — an important localizing clue.

Common Mistakes

  • Swinging the light too slowly, allowing both pupils time to re-dilate in darkness between stimulations and obscuring the direct comparison the test relies on.
  • Testing in a room that is too bright or too dark, either preventing any visible pupillary response or making the resting size impossible to assess.
  • Failing to have the patient fixate on a distant target, introducing a near-response miosis confound.
  • Missing a subtle RAPD by not swinging the light back and forth enough times or not watching closely enough for a partial (rather than fully paradoxical) response.

OSCE Script

"I'm going to shine this light in your eyes and move it back and forth — please just look straight ahead at the wall behind me the whole time."

Then narrate for the examiner: "I'm assessing for a relative afferent pupillary defect by swinging the light between the two eyes every few seconds and comparing the briskness and degree of constriction in each."

Clinical Pearls

  • A positive RAPD is one of the most objective, reliable bedside signs in neuro-ophthalmology, since it does not depend on subjective patient report and cannot be feigned or reliably suppressed
  • RAPD reflects afferent pathway asymmetry, not visual acuity per se — a patient can have severely reduced acuity in one eye from a refractive or media cause without any RAPD, while a relatively mild but asymmetric optic neuropathy can produce a clearly positive RAPD
  • Neutral density filter grading provides a useful, semi-quantitative way to document RAPD severity and track change over time
  • Emerging cell phone-based and automated pupillometry tools show promise for RAPD screening by non-specialists, with one validated application achieving high sensitivity (93%) and specificity (85%) against neuro-ophthalmologist assessment, offering a potentially valuable aid particularly for providers less experienced with the manual technique1
  • However, objective pupillometry without careful methodological control can show substantial measurement variability even in healthy individuals, generating potential false positives — reinforcing that automated tools currently supplement rather than replace skilled manual testing, and that robust normative cutoffs still require further validation2

Common Pitfalls

  • Assuming a "positive RAPD" from an automated pupillometry score without correlating it with careful manual testing and the broader clinical picture, given documented variability in automated measurements2
  • Overlooking a subtle or mild RAPD by rushing through the test or not swinging the light enough times to build a confident comparison
  • Misinterpreting an efferent (motor) pupillary abnormality, such as a third nerve palsy or pharmacologic mydriasis, as a relative afferent pupillary defect
  • Failing to correlate a positive RAPD with the rest of the neuro-ophthalmic exam (visual acuity, color vision, visual fields, fundus exam) to localize the underlying cause

References

  1. [1]Lavertu G, et al. Validation of a new cell phone application for quick screening of relative afferent pupillary defect. Canadian Journal of Ophthalmology. 2025.
  2. [2]Kahrhoff MA, Bassi CJ. Does EyeKinetix pupillometry clarify RAPD detection? Documenta Ophthalmologica. 2026.